otcaddict, I was not referring to remdesivir study
Post# of 148165
(Total Views: 749)
Posted On: 11/20/2020 1:06:14 AM
otcaddict, I was not referring to remdesivir study, was referring to remestemcel-L study by Mesoblast.
The context was NP touting leronlimab is only trial with mortality as PE.
In NP's defense, however, he does have a few CYA moments when he says "that I'm aware of" or "we're the only one, (mumble, mumble) or 2 or 3."
https://www.clinicaltrials.gov/ct2/show/NCT04371393
The context was NP touting leronlimab is only trial with mortality as PE.
In NP's defense, however, he does have a few CYA moments when he says "that I'm aware of" or "we're the only one, (mumble, mumble) or 2 or 3."
https://www.clinicaltrials.gov/ct2/show/NCT04371393
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼